Noticias y Notas de Prensa
Promega Biotech Ibérica S.L, filial de la multinacional norteamericana Promega Corporation, cumple 15 años en España y Portugal desarrollando prácticas sostenibles en todos los aspectos de nuestro negocio. Prestamos especial atención a las relaciones internas y externas con clientes, proveedores, empleados y las comunidades con las que interaccionamos. Los 4.000 productos del catálogo van destinados a centros de investigación, universidades, hospitales, colectivos como las Fuerzas y Cuerpos de Seguridad del Estado, así como a empresas farmacéuticas y biotecnológicas con I+D en España.
Notas de Prensa Globales
2025
Promega HiBiT-PsVLP Bioassay to Aid Global Vaccine ResearchApril 15 • 2 min read
Promega a 2025 USA TODAY Top Workplace Award WinnerMarch 20 • 2 min read
Promega Files Patent Infringement Lawsuit Against Aobious to Protect Novel Luciferase SubstratesMarch 5 • 2 min read
Promega Spring Art Showcase Presents “Eternal Cycles"February 18 • 2 min read
Promega PowerPlex® 35GY System, First 8-Color STR Kit, Approved for NDIS by FBIFebruary 4 • 2 min read
Promega Recognized with Diversity and Inclusion Award from Wisconsin Society for Human Resource ManagementJanuary 14 • 2 min read
2024
Promega Named a BioSpace 2025 Best Places to Work WinnerNovember 13 • 2 min read
Promega and QuantumCyte Sign Co-Marketing Agreement, Present Joint Poster at Association for Molecular Pathology (AMP) 2024 MeetingNovember 12 • 2 min read
Promega Unveils GloMax® Galaxy Bioluminescence Imager for Illuminating Protein Dynamics in Real TimeOctober 1 • 2 min read
Promega Engineers New Enzyme to Significantly Reduce Stutter in Forensic DNA AnalysisSeptember 25 • 2 min read
Promega Fall Art Showcase Presents “From This Place: Three Photographers”August 6 • 2 min read
35th International Symposium on Human Identification (ISHI) Highlights Intersection of True Crime Media and DNA ForensicsJuly 31 • 2 min read
Promega Maxwell® DE System Accelerates Sexual Assault Kit Processing with Automated ProtocolJuly 9 • 2 min read
Promega Launches Portable 96-Well Plate Reader to Analyze Luminescent Cell Health AssaysJune 11 • 2 min read
Promega Contributes to New Study on Reversible, Non-Hormonal Male ContraceptionJune 4 • 2 min read
Promega Summer Art Showcase Presents “Collections Unveiled”May 23 • 2 min read
Promega Highlights Progress in Sustainability, Employee Wellbeing and Community Engagement in 2024 Corporate Responsibility ReportMay 22 • 2 min read
Promega Kit Enables European Forensic Labs to Solve Challenging Cold CasesMay 7 • 2 min read
INOVIQ and Promega Sign Global Supply and Distribution Agreement for EXO-NET®April 18 • 2 min read
Promega Spring Art Showcase 2024 Presents “Visions of Consciousness”February 15 • 2 min read
eLabNext Partners with Promega to Make Product Protocols Accessible for eLabProtocols UsersJanuary 16 • 2 min read
Promega Research Shows Potential of Selective Degrader Against Pediatric Cancer Cell LinesJanuary 16 • 2 min read
2023
BioLabs and Promega announce collaboration to support young biotech companiesDecember 14 • 2 min read
Promega Named a BioSpace 2024 Best Places to Work WinnerNovember 8 • 2 min read
Live-Cell Assays Reveal Two Reported Anti-Inflammation Molecules Fail to Engage Target ProteinOctober 25 • 2 min read
Promega to Develop Microsatellite Instability (MSI) Companion Diagnostic IVD Kit in collaboration with GSKOctober 3 • 2 min read
Promega Fall Art Showcase 2023 to Honor Artist Truman LoweSeptember 6 • 2 min read
CRISPR-Cas9 Knock-In Efficiency Enhanced Using Small-Molecule Inhibitor Pair, Study ShowsAugust 21 • 2 min read
Innovative research for malaria control driven by three collaborating parties: Swiss TPH, BASF and PromegaAugust 17 • 2 min read
Promega and BTC Institute D.O.O.R.S Scholarship Recognizes STEM Students from Underrepresented BackgroundsAugust 14 • 2 min read
"En un momento en el que algunos consideran que las necesidades de nuestro mundo son abrumadoras, los esfuerzos individuales pueden parecer inútiles, sin embargo, la influencia de un individuo es justo lo que necesitamos."
—William A. Linton, Presidente y CEO